IRIS
CAMELI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.299
NA - Nord America 5.383
AS - Asia 1.056
AF - Africa 73
SA - Sud America 22
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.343
IT - Italia 2.229
IE - Irlanda 1.644
GB - Regno Unito 1.531
RU - Federazione Russa 750
SE - Svezia 698
SG - Singapore 381
DE - Germania 374
FR - Francia 356
CN - Cina 313
FI - Finlandia 248
UA - Ucraina 164
IN - India 100
ES - Italia 98
VN - Vietnam 76
CZ - Repubblica Ceca 65
CI - Costa d'Avorio 57
CA - Canada 32
IR - Iran 28
HK - Hong Kong 25
NL - Olanda 25
AU - Australia 19
BE - Belgio 18
KR - Corea 14
PH - Filippine 14
PK - Pakistan 14
TR - Turchia 14
AT - Austria 13
CH - Svizzera 13
JP - Giappone 11
DK - Danimarca 9
PL - Polonia 9
BG - Bulgaria 7
MK - Macedonia 7
PT - Portogallo 7
BD - Bangladesh 6
EU - Europa 6
HU - Ungheria 6
PE - Perù 6
AZ - Azerbaigian 5
CL - Cile 5
ID - Indonesia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
LV - Lettonia 5
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
EG - Egitto 4
GE - Georgia 4
GR - Grecia 4
MX - Messico 4
UZ - Uzbekistan 4
AL - Albania 3
AR - Argentina 3
LT - Lituania 3
RS - Serbia 3
ZA - Sudafrica 3
CO - Colombia 2
CY - Cipro 2
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
IS - Islanda 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
AM - Armenia 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MM - Myanmar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TH - Thailandia 1
Totale 14.860
Salva come PNG Salva come JPEG
Città #
Dublin 1.614
Southend 1.442
Fairfield 730
Chandler 715
Ashburn 495
Siena 470
Woodbridge 321
Lastra a Signa 314
Wilmington 303
Singapore 302
Houston 278
Seattle 251
Princeton 230
Cambridge 228
Helsinki 214
Ann Arbor 146
New York 141
Florence 140
Jacksonville 101
Milan 100
Munich 95
Shanghai 84
Beijing 76
San Mateo 76
Dong Ket 75
Moscow 71
Fremont 70
Málaga 68
Rome 65
San Diego 63
Abidjan 57
Dearborn 51
Boardman 48
Brno 44
Los Angeles 37
London 31
Dallas 29
Washington 29
Gavirate 26
Chicago 22
Gießen 19
Agliana 18
Brussels 18
Guangzhou 18
Lappeenranta 18
Nanjing 18
Naples 17
Olomouc 17
Padova 17
Tarazona 17
Hong Kong 16
Livorno 16
Nuremberg 16
Santa Clara 16
Hyderabad 15
Toronto 14
Redwood City 13
Vienna 13
Brescia 12
Norwalk 12
Zanjan 12
Aachen 11
Changsha 11
Chianciano Terme 10
Comun Nuovo 10
Nanchang 10
Pasig 10
Pisa 10
Izmir 9
Lahore 9
Melbourne 9
San Francisco 9
Amsterdam 8
Bangalore 8
Bergamo 8
Delhi 8
Grosseto 8
Kilburn 8
Leawood 8
Newark 8
Paris 8
Phoenix 8
Prato 8
Zurich 8
Bologna 7
Cagliari 7
Carrara 7
Catania 7
Pune 7
Salerno 7
San Casciano in Val di Pesa 7
Sofia 7
Zhengzhou 7
Anagni 6
Barcelona 6
Budapest 6
Dhaka 6
Espoo 6
Falkenstein 6
Hefei 6
Totale 10.293
Salva come PNG Salva come JPEG
Nome #
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 200
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 199
Genetic mechanisms of critical illness in COVID-19 199
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6 195
Peripheral biomarkers' panel for severe COVID-19 patients 192
Exhaled nitric oxide in interstitial lung diseases 188
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 188
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 182
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 174
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 173
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 166
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 165
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 163
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 155
NK and NKT-like cells in granulomatous and fibrotic lung diseases 152
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 152
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 151
Incremental value of pocket-sized imaging device for bedside diagnosis of unilateral pleural effusions and ultrasound-guided thoracentesis 146
Prognostic bioindicators in severe COVID-19 patients 139
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 138
Comparison of Right Versus Left Ventricular Strain Analysis as a Predictor of Outcome in Patients With Systolic Heart Failure Referred for Heart Transplantation 137
Serum amyloid A in patients with idiopathic pulmonary fibrosis 137
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 137
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 132
Pathogen-sugar interactions revealed by universal saturation transfer analysis 131
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 130
Serial KL-6 measurements in COVID-19 patients 125
Mapping the human genetic architecture of COVID-19 125
Omalizumab treatment in Samter's triad: case series and review of the literature 124
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 123
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 121
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 119
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 118
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 118
Traditional and Novel Imaging of Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction 118
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 117
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 117
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 116
Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings 116
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 115
Serum amyloid A: A potential biomarker of lung disorders 113
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 113
A first update on mapping the human genetic architecture of COVID-19 112
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 112
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 112
null 111
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 111
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor 109
ACUTE HF score, a multiparametric prognostic tool for acute heart failure: A real-life study 107
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 107
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 107
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 107
null 106
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy 106
The impact of antifibrotic therapy in the management of idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world comparative study of efficacy between pirfenidone and nintedanib 105
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 104
An explainable model of host genetic interactions linked to COVID-19 severity 103
Effects of rituximab therapy on B cell differentiation and depletion 103
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 102
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation 102
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 101
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 100
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 99
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 99
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 98
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 98
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation 97
Safe performance of echocardiography during the COVID-19 pandemic: A practical guide 97
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 97
WES profiling of COVID-19 96
Basic and advanced echocardiography in advanced heart failure: an overview 95
Serum KL-6 levels in Pulmonary Langerhans' Cell Histiocytosis 95
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? 95
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers 95
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 95
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 94
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 92
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 92
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 91
Immunologic responses to antifibrotic treatment in IPF patients 91
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 90
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 90
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 87
Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases 87
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 86
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 86
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 85
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 85
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 85
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment 85
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients 84
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 81
Clinical and molecular characterization of COVID-19 hospitalized patients 79
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review 78
Clinical phenotyping in sarcoidosis management 78
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab 77
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 77
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 77
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 76
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 74
Totale 11.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020820 0 0 0 0 90 97 96 135 113 112 71 106
2020/20212.752 90 113 141 352 297 298 211 344 265 174 239 228
2021/20222.553 187 281 225 182 124 114 110 118 114 321 269 508
2022/20233.028 200 342 390 305 186 521 261 265 210 123 127 98
2023/20243.392 132 93 328 173 170 737 956 193 56 119 127 308
2024/20252.484 607 312 846 453 266 0 0 0 0 0 0 0
Totale 15.698